LOS ANGELES, Aug. 18, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Capricor Therapeutics, Inc. ("Capricor" or "the Company") (NASDAQ: CAPR) for violations of §§10(b) and 20(a) of the Securities...
Related Questions
What potential financial impact could the securities fraud lawsuit have on Capricor Therapeutics' valuation?
How might the lawsuit affect the short‑term trading dynamics and liquidity of CAPR stock?
What is the expected timeline for the case resolution and could it trigger further regulatory scrutiny or insider actions?